Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Alrosa will hold an auction of investment diamonds

4/17/24 ALRS

MTS may bring its media holding to IPO

4/17/24 MTSS

Smartofood has opened a round of investment raising

4/17/24 OTCI

Magnit will multiply the network of hard discounters

4/17/24 MGNT

MGKL launched its store on Ozon

4/17/24 MGKL

X5 Retail Group will distribute accumulated funds in favor of shareholders

4/17/24 X5

Astra has set the lower boundary of the SPO

4/17/24 ASTR

Uralsib reported for 2023 by IFRS

4/17/24 USBN

Moscow Exchange plans to hold Pre-IPO in Q2

4/17/24 MOEX

Moscow Exchange plans to hold Pre-IPO in Q2

4/17/24 OTCI